3Wood WC, Budman DR, Korzun AH, et al. Dose and dose intensiy of adjuvant chemotherapy for stage Ⅱ, node positive breast carcinoma [J]. N Engl J Med,1994,330(18) :1253.
4El-Sayyad HI, Ismail MF, Shalaby FM, et al. Histopathological effects of cisplatin, doxorubicin and 5-flurouracil ( 5-FU ) on the liver of male albino rats [ J ]. Int J Biol Sci, 2009,5 ( 5 ) :466 -473.
5Okamoto R, Maeda Y, Sasaki T. Hepatotoxicity of chemotherapy [ J ]. Gan To Kagaku Ryoho,2003,30(6) :772-778.
6ShiroLino,Toshiro Tango, Takashi Matsushima, et al. Therapentie effects of stronger Neo-Minophager C at different doses on chronic hepatitis and liver cirrhosis [ J ]. Hepatology Research,2001,19:31-40.
7Danan G, Benichou C. Causality assessment of adverse reactions to drugs-I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries. J Clin Epidemiol, 1993, 46: 1323-1330.
8Benichou C. Criteria of drug-induced liver disorders. Report of an international consensus meeting. J Hepatol, 1990, 11: 272-276.
9Fontana RJ, Seeff LB, Andrade RJ, et al. Standardization of nomenclature and causality assessment in drug-induced liver injury: summary of a clinical research workshop. Hepatology, 2010, 52: 730-742.
10Ishak K, Baptista A, Bianchi L, et al. Histological grading and staging of chronic hepatitis. J Hepatol, 1995, 22: 696-699.
